{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:54:51Z","timestamp":1794387291801,"version":"4.9.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071697"],"award-info":[{"award-number":["R01AG071697"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG076647"],"award-info":[{"award-number":["RF1AG076647"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG073082"],"award-info":[{"award-number":["P01AG073082"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG074690"],"award-info":[{"award-number":["F31AG074690"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["F31AG074672"],"award-info":[{"award-number":["F31AG074672"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P3AG072980"],"award-info":[{"award-number":["P3AG072980"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG059751"],"award-info":[{"award-number":["RF1AG059751"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Apolipoprotein E4 (\n                    <jats:italic>APOE4<\/jats:italic>\n                    ) is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease (LOAD), leading to earlier age of clinical onset and exacerbating pathologies. There is a critical need to identify protective targets. Recently, a rare APOE variant, APOE3-R136S (Christchurch), was found to protect against early-onset AD in a PSEN1-E280A carrier. In this study, we sought to determine if the R136S mutation also protects against APOE4-driven effects in LOAD. We generated tauopathy mouse and human iPSC-derived neuron models carrying human APOE4 with the homozygous or heterozygous R136S mutation. We found that the homozygous R136S mutation rescued APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. The heterozygous R136S mutation partially protected against APOE4-driven neurodegeneration and neuroinflammation but not Tau pathology. Single-nucleus RNA sequencing revealed that the APOE4-R136S mutation increased disease-protective and diminished disease-associated cell populations in a gene dose-dependent manner. Thus, the APOE-R136S mutation protects against APOE4-driven AD pathologies, providing a target for therapeutic development against AD.\n                  <\/jats:p>","DOI":"10.1038\/s41593-023-01480-8","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T12:02:08Z","timestamp":1699876928000},"page":"2104-2121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-5099","authenticated-orcid":false,"given":"Maxine R.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-8926","authenticated-orcid":false,"given":"Ayushi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-7167","authenticated-orcid":false,"given":"Oscar","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Traglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-1480","authenticated-orcid":false,"given":"Nicole","family":"Koutsodendris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-018X","authenticated-orcid":false,"given":"Antara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Grone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Yeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzing","family":"Choenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-1484","authenticated-orcid":false,"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-8244","authenticated-orcid":false,"given":"Yakeel T.","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Arboleda-Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0705-3696","authenticated-orcid":false,"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mahley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4589","authenticated-orcid":false,"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"1480_CR1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204\u20131222 (2012).","journal-title":"Cell"},{"key":"1480_CR2","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley, R. W., Weisgraber, K. H. & Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 103, 5644\u20135651 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72PA","author":"Y Huang","year":"2014","unstructured":"Huang, Y. & Mahley, R. W. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol. Dis. 72PA, 3\u201312 (2014).","journal-title":"Neurobiol. Dis."},{"key":"1480_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris, N., Nelson, M. R., Rao, A. & Huang, Y. Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms. Annu. Rev. Pathol. 17, 73\u201399 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"1480_CR5","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris, F. M., Brecht, W. J., Xu, Q., Mahley, R. W. & Huang, Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J. Biol. Chem. 279, 44795\u201344801 (2004).","journal-title":"J. Biol. Chem."},{"key":"1480_CR6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."},{"key":"1480_CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"1480_CR8","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht, W. J. et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24, 2527\u20132534 (2004).","journal-title":"J. Neurosci."},{"key":"1480_CR9","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling, Y. et al. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 30, 13707\u201313717 (2010).","journal-title":"J. Neurosci."},{"key":"1480_CR10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li, G. et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5, 634\u2013645 (2009).","journal-title":"Cell Stem Cell"},{"key":"1480_CR11","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019).","journal-title":"J. Exp. Med."},{"key":"1480_CR12","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR13","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1038\/s41380-020-0688-6","volume":"26","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and tau pathologies. Mol. Psychiatry 26, 5977\u20135988 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1480_CR14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.neuron.2018.06.011","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin, Y.-T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1294 (2018).","journal-title":"Neuron"},{"key":"1480_CR15","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat. Commun. 11, 5540 (2020).","journal-title":"Nat. Commun."},{"key":"1480_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","volume":"156","author":"I Tesseur","year":"2000","unstructured":"Tesseur, I. et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156, 951\u2013964 (2000).","journal-title":"Am. J. Pathol."},{"key":"1480_CR17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"1480_CR18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"1480_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck, G. W., Reiter, J. S., Strickland, D. K. & Hyman, B. T. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron 11, 575\u2013580 (1993).","journal-title":"Neuron"},{"key":"1480_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","volume":"38","author":"A Ward","year":"2012","unstructured":"Ward, A. et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 38, 1\u201317 (2012).","journal-title":"Neuroepidemiology"},{"key":"1480_CR21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley, R. W. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J. Mol. Med. (Berl.) 94, 739\u2013746 (2016).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"1480_CR22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky, K. A. et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat. Neurosci. 24, 786\u2013798 (2021).","journal-title":"Nat. Neurosci."},{"key":"1480_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","volume":"134","author":"SC Gale","year":"2014","unstructured":"Gale, S. C. et al. APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects. J. Allergy Clin. Immunol. 134, 127\u2013134 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1480_CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","volume":"8","author":"R Egensperger","year":"1998","unstructured":"Egensperger, R., K\u00f6sel, S., von Eitzen, U. & Graeber, M. B. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol. 8, 439\u2013447 (1998).","journal-title":"Brain Pathol."},{"key":"1480_CR25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000017128","volume":"10","author":"M Overmyer","year":"1999","unstructured":"Overmyer, M. et al. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. Dement. Geriatr. Cogn. Disord. 10, 252\u2013257 (1999).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"1480_CR26","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0601-z","volume":"13","author":"T Minett","year":"2016","unstructured":"Minett, T. et al. Microglial immunophenotype in dementia with Alzheimer\u2019s pathology. J. Neuroinflammation 13, 135 (2016).","journal-title":"J. Neuroinflammation"},{"key":"1480_CR27","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu, Q. et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985\u20134994 (2006).","journal-title":"J. Neurosci."},{"key":"1480_CR28","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","volume":"28","author":"Q Xu","year":"2008","unstructured":"Xu, Q. et al. Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 28, 1452\u20131459 (2008).","journal-title":"J. Neurosci."},{"key":"1480_CR29","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","volume":"263","author":"JR Wetterau","year":"1988","unstructured":"Wetterau, J. R., Aggerbeck, L. P., Rall, S. C. & Weisgraber, K. H. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263, 6240\u20136248 (1988).","journal-title":"J. Biol. Chem."},{"key":"1480_CR30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber, K. H. Apolipoprotein E: structure\u2013function relationships. Adv. Protein Chem. 45, 249\u2013302 (1994).","journal-title":"Adv. Protein Chem."},{"key":"1480_CR31","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","volume":"256","author":"KH Weisgraber","year":"1981","unstructured":"Weisgraber, K. H., Rall, S. C. & Mahley, R. W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256, 9077\u20139083 (1981).","journal-title":"J. Biol. Chem."},{"key":"1480_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley, R. W. & Rall, S. C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genom. Hum. Genet. 1, 507\u2013537 (2000).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"1480_CR33","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1074\/jbc.273.22.13452","volume":"273","author":"Z-S Ji","year":"1998","unstructured":"Ji, Z.-S., Pitas, R. E. & Mahley, R. W. Differential cellular accumulation\/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 273, 13452\u201313460 (1998).","journal-title":"J. Biol. Chem."},{"key":"1480_CR34","doi-asserted-by":"crossref","first-page":"39138","DOI":"10.1074\/jbc.M104746200","volume":"276","author":"CP Libeu","year":"2001","unstructured":"Libeu, C. P. et al. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 276, 39138\u201339144 (2001).","journal-title":"J. Biol. Chem."},{"key":"1480_CR35","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1021\/bi8003999","volume":"47","author":"Y Yamauchi","year":"2008","unstructured":"Yamauchi, Y. et al. Role of the N- and C-Terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry 47, 6702\u20136710 (2008).","journal-title":"Biochemistry"},{"key":"1480_CR36","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez, J. F. et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 25, 1680\u20131683 (2019).","journal-title":"Nat. Med."},{"key":"1480_CR37","doi-asserted-by":"crossref","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"C-C Liu","year":"2021","unstructured":"Liu, C.-C. et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci. Transl. Med. 13, eabc9375 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1480_CR38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).","journal-title":"Nat. Commun."},{"key":"1480_CR39","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-9-11","volume":"9","author":"CW Medway","year":"2014","unstructured":"Medway, C. W. et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease. Mol. Neurodegen. 9, 11 (2014).","journal-title":"Mol. Neurodegen."},{"key":"1480_CR40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen, Y. et al. Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease. JAMA Neurol. 79, 652\u2013663 (2022).","journal-title":"JAMA Neurol."},{"key":"1480_CR41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","volume":"75","author":"YT Quiroz","year":"2018","unstructured":"Quiroz, Y. T. et al. Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease. JAMA Neurol. 75, 548\u2013556 (2018).","journal-title":"JAMA Neurol."},{"key":"1480_CR42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","volume":"2","author":"CA Lemere","year":"1996","unstructured":"Lemere, C. A. et al. The E280A presenilin 1 Alzheimer mutation produces increased A\u03b2 42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146\u20131150 (1996).","journal-title":"Nat. Med."},{"key":"1480_CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-022-02467-8","volume":"144","author":"D Sepulveda-Falla","year":"2022","unstructured":"Sepulveda-Falla, D. et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer\u2019s dementia. Acta Neuropathol. 144, 589\u2013601 (2022).","journal-title":"Acta Neuropathol."},{"key":"1480_CR44","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41591-019-0634-9","volume":"25","author":"KA Zalocusky","year":"2019","unstructured":"Zalocusky, K. A., Nelson, M. R. & Huang, Y. An Alzheimer\u2019s-disease-protective APOE mutation. Nat. Med. 25, 1648\u20131649 (2019).","journal-title":"Nat. Med."},{"key":"1480_CR45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","volume":"80","author":"MR Wardell","year":"1987","unstructured":"Wardell, M. R., Brennan, S. O., Janus, E. D., Fraser, R. & Carrell, R. W. Apolipoprotein E2-Christchurch (136 Arg\u2013Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J. Clin. Invest. 80, 483\u2013490 (1987).","journal-title":"J. Clin. Invest."},{"key":"1480_CR46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch, J. N. et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs). Sci. Rep. 8, 6382 (2018).","journal-title":"Sci. Rep."},{"key":"1480_CR47","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","volume":"293","author":"BE Stopschinski","year":"2018","unstructured":"Stopschinski, B. E. et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau vs. \u03b1-synuclein and \u03b2-amyloid aggregates. J. Biol. Chem. 293, 10826\u201310840 (2018).","journal-title":"J. Biol. Chem."},{"key":"1480_CR48","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. & Diamond, M. I. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J. Biol. Chem. 289, 19855\u201319861 (2014).","journal-title":"J. Biol. Chem."},{"key":"1480_CR49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1480_CR50","doi-asserted-by":"crossref","unstructured":"Congdon, E. E. & Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 399\u2013415 (2018).","DOI":"10.1038\/s41582-018-0013-z"},{"key":"1480_CR51","doi-asserted-by":"crossref","first-page":"590896","DOI":"10.3389\/fnmol.2020.590896","volume":"13","author":"Y Soeda","year":"2020","unstructured":"Soeda, Y. & Takashima, A. New insights into drug discovery targeting tau protein. Front. Mol. Neurosci. 13, 590896 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"1480_CR52","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y. & Huang, Y. Reducing human apolipoprotein E levels attenuates age-dependent a\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803\u20134811 (2012).","journal-title":"J. Neurosci."},{"key":"1480_CR53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"1480_CR54","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-017-0442-8","volume":"5","author":"SK Kaufman","year":"2017","unstructured":"Kaufman, S. K., Thomas, T. L., Del Tredici, K., Braak, H. & Diamond, M. I. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathol. Commun. 5, 41 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"1480_CR55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N. et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat. Aging 3, 275\u2013296 (2023).","journal-title":"Nat. Aging"},{"key":"1480_CR56","doi-asserted-by":"crossref","first-page":"107962","DOI":"10.1016\/j.celrep.2020.107962","volume":"32","author":"R Najm","year":"2020","unstructured":"Najm, R. et al. In vivo chimeric Alzheimer\u2019s disease modeling of apolipoprotein E4 toxicity in human neurons. Cell Rep. 32, 107962 (2020).","journal-title":"Cell Rep."},{"key":"1480_CR57","first-page":"E3138","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes, B. B. et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl Acad. Sci. USA 110, E3138\u2013E3147 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1480_CR58","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","volume":"263","author":"A Lalazar","year":"1988","unstructured":"Lalazar, A. et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263, 3542\u20133545 (1988).","journal-title":"J. Biol. Chem."},{"key":"1480_CR59","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley, R. W. & Huang, Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76, 871\u2013885 (2012).","journal-title":"Neuron"},{"key":"1480_CR60","doi-asserted-by":"crossref","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).","journal-title":"J. Stat. Mech."},{"key":"1480_CR61","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"1480_CR62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"1480_CR63","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"1480_CR64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C. E. G. & Holtzman, D. M. Glial contributions to neurodegeneration in tauopathies. Mol. Neurodegener. 12, 50 (2017).","journal-title":"Mol. Neurodegener."},{"key":"1480_CR65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505\u2013508 (2014).","journal-title":"JAMA Neurol."},{"key":"1480_CR66","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. Psychiatry 26, 5481\u20135503 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1480_CR67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira, J. B. et al. Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain 144, 310\u2013324 (2021).","journal-title":"Brain"},{"key":"1480_CR68","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","volume":"4","author":"C Geula","year":"1998","unstructured":"Geula, C. et al. Aging renders the brain vulnerable to amyloid\u03b2-protein neurotoxicity. Nat. Med. 4, 827\u2013831 (1998).","journal-title":"Nat. Med."},{"key":"1480_CR69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"1480_CR70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jbiotec.2016.11.011","volume":"241","author":"X Liang","year":"2017","unstructured":"Liang, X., Potter, J., Kumar, S., Ravinder, N. & Chesnut, J. D. Enhanced CRISPR\/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J. Biotechnol. 241, 136\u2013146 (2017).","journal-title":"J. Biotechnol."},{"key":"1480_CR71","doi-asserted-by":"crossref","first-page":"e0124633","DOI":"10.1371\/journal.pone.0124633","volume":"10","author":"M Stemmer","year":"2015","unstructured":"Stemmer, M. et al. CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool. PLoS ONE 10, e0124633 (2015).","journal-title":"PLoS ONE"},{"key":"1480_CR72","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).","journal-title":"Genome Biol."},{"key":"1480_CR73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"1480_CR74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"1480_CR75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.scr.2018.08.003","volume":"31","author":"Y-H Chen","year":"2018","unstructured":"Chen, Y.-H. & Pruett-Miller, S. M. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells. Stem Cell Res. 31, 186\u2013192 (2018).","journal-title":"Stem Cell Res."},{"key":"1480_CR76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature 533, 125\u2013129 (2016).","journal-title":"Nature"},{"key":"1480_CR77","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas, C. A. et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat. Med. 24, 1216\u20131224 (2018).","journal-title":"Nat. Med."},{"key":"1480_CR78","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1101\/gr.244293.118","volume":"29","author":"K Labun","year":"2019","unstructured":"Labun, K. et al. Accurate analysis of genuine CRISPR editing events with ampliCan. Genome Res 29, 843\u2013847 (2019).","journal-title":"Genome Res"},{"key":"1480_CR79","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","volume":"3","author":"TJ Cradick","year":"2014","unstructured":"Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J. & Bao, G. COSMID: a web-based tool for identifying and validating CRISPR\/Cas off-target sites. Mol. Ther. Nucleic Acids 3, e214 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1480_CR80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194\u2013208 (2020).","journal-title":"Nat. Neurosci."},{"key":"1480_CR81","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"1480_CR82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22, 433 (2021).","journal-title":"BMC Bioinformatics"},{"key":"1480_CR83","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1093\/nar\/gkv1290","volume":"44","author":"R Agarwala","year":"2016","unstructured":"Agarwala, R. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 44, D7\u2013D19 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1480_CR84","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe, K. L. et al. Ensembl 2021. Nucleic Acids Res. 49, D884\u2013D891 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1480_CR85","doi-asserted-by":"crossref","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1480_CR86","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"1480_CR87","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"1480_CR88","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"1480_CR89","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1093\/bioinformatics\/btaa1009","volume":"36","author":"C Ahlmann-Eltze","year":"2021","unstructured":"Ahlmann-Eltze, C. & Huber, W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics 36, 5701\u20135702 (2021).","journal-title":"Bioinformatics"},{"key":"1480_CR90","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2, 100141 (2021).","journal-title":"Innovation (Camb.)"},{"key":"1480_CR91","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1480_CR92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"1480_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects models using lme4. J. Stat. Soft. 67, 1\u201348 (2015).","journal-title":"J. Stat. Soft."},{"key":"1480_CR94","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3758\/s13428-014-0477-8","volume":"47","author":"G Shieh","year":"2015","unstructured":"Shieh, G. & Jan, S.-L. Optimal sample size allocation for Welch\u2019s test in one-way heteroscedastic ANOVA. Behav. Res. Methods 47, 374\u2013383 (2015).","journal-title":"Behav. Res. Methods"},{"key":"1480_CR95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bmsp.12006","volume":"67","author":"S-L Jan","year":"2014","unstructured":"Jan, S.-L. & Shieh, G. Sample size determinations for Welch\u2019s test in one-way heteroscedastic ANOVA. Br. J. Math. Stat. Psychol. 67, 72\u201393 (2014).","journal-title":"Br. J. Math. Stat. Psychol."},{"key":"1480_CR96","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/01621459.1980.10477552","volume":"75","author":"CW Dunnett","year":"1980","unstructured":"Dunnett, C. W. Pairwise multiple comparisons in the unequal variance case. J. Am. Stat. Assoc. 75, 796\u2013800 (1980).","journal-title":"J. Am. Stat. Assoc."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01480-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01480-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01480-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T18:43:11Z","timestamp":1730486591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01480-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1038\/s41593-023-01480-8","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"23 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Huang and R.W.M. are involved in establishing and managing GABAeron, Inc. Q.X. works part time at GABAeron, Inc. J.F.A.-V. is a co-inventor on a patent application describing methods and compositions for the treatment of Alzheimer\u2019s disease via APOE Christchurch. Other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}